Our biologic is modular and CD19 may be exchanged for other cell surface biomarkers such as CD22, CD133, Her-2, EGFR, mesothelin, and others [47,48], and the JAM may be any of the four members of the subfamily, whichever is relevant to the tumor tissue of origin. The gene discussed is CD19; the disease is neoplasm.